High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation - normalized miRNA expression with clinical variables

Similar Items

• Figure 3. miRNA expression in patients with progressive disease (group 1) compared with patients with clinical benefit (stable disease + partial response + complete response; group 2). Statistically significant miR expression levels of (A) miR-200b, (B) miR-34a, (C) miR-21, (D) miR-200a and (E) miR-193b. miR, microRNA.
  by: Kubeczko, Marcin, et al.
  Published: (2024)
• Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma
  by: Samer Al Hadidi, et al.
  Published: (2024)
• Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
  by: Taku Kikuchi, et al.
  Published: (2024)
• Correction to “Extracellular vesicular miRNA expression is not a proxy for skeletal muscle miRNA expression in males and females following acute, moderate intensity exercise”
  Published: (2024)
• Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma
  by: Stephanie Yohay, et al.
  Published: (2024)